(Q44736260)

5 December 2017

title

Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects (English)

1 reference

5 December 2017

0 references

Stefan Cohrs

1

1 reference

5 December 2017

Kathrin Pohlmann

2

1 reference

5 December 2017

Zhenghua Guan

3

1 reference

5 December 2017

Wolfgang Jordan

4

1 reference

5 December 2017

Andreas Meier

5

1 reference

5 December 2017

Gerald Huether

6

1 reference

5 December 2017

Eckart Rüther

7

1 reference

5 December 2017

Andrea Rodenbeck

8

1 reference

5 December 2017

publication date

20 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

volume

174

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

414-420

1 reference

Effects of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desimipramine-induced pituitary hormone stimulation in humans--III. Hypothalamo-pituitary-adrenocortical axis

5 December 2017

cites work

1 reference

12 December 2020

HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment

1 reference

12 December 2020

Effect of the serotonin antagonists ritanserin and ketanserin in Cushing's disease

1 reference

12 December 2020

Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms

1 reference

12 December 2020

The corticosteroid receptor hypothesis of depression

1 reference

12 December 2020

Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man.

1 reference

12 December 2020

Clinical use of quetiapine in disease states other than schizophrenia.

1 reference

12 December 2020

The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia

1 reference

12 December 2020

Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics

1 reference

12 December 2020

Melatonin Improves Sleep Quality of Patients With Chronic Schizophrenia

1 reference

12 December 2020

Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.

1 reference

12 December 2020

Diurnal melatonin and cortisol secretion profiles in medicated schizophrenic patients.

1 reference

12 December 2020

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

12 December 2020

Suppression of HPA-axis activity by haloperidol after experimentally induced heat stress

1 reference

12 December 2020

The effects of a number of short-term exogenous stimuli on pineal serotonin-N-acetyltransferase activity in rats

1 reference

12 December 2020

Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.

1 reference

12 December 2020

Effects of neuroleptic treatment on cortisol and 3-methoxy-4-hydroxyphenylethyl glycol levels in blood.

1 reference

12 December 2020

Neuroendocrine responses to single oral doses of remoxipride and sulpiride in healthy female and male volunteers

1 reference

12 December 2020

The effect of neuroleptic drugs on serum and cerebrospinal fluid melatonin concentrations in psychiatric subjects

1 reference

12 December 2020

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

1 reference

12 December 2020

Switch from neuroleptics to clozapine does not influence pituitary–gonadal axis hormone levels in male schizophrenic patients

1 reference

12 December 2020

The human pineal gland responds to stress-induced sympathetic activation in the second half of the dark phase: preliminary evidence

1 reference

12 December 2020

Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II

1 reference

12 December 2020

Cyproheptadine inhibits the corticotropin releasing hormone (CRH)--induced hormone release in normal subjects

1 reference

12 December 2020

Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine

1 reference

12 December 2020

Neuroendocrine responses in chronic schizophrenia. Evidence for serotonergic dysfunction.

1 reference

12 December 2020

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

1 reference

12 December 2020

Melatonin and N-acetylserotonin stress responses: effects of type of stimulation and housing conditions.

1 reference

12 December 2020

Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man.

1 reference

12 December 2020

Haloperidol increases plasma beta endorphin-like immunoreactivity and cortisol in normal human males

1 reference

12 December 2020

The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks

1 reference

12 December 2020

Effect of adrenergic receptor blockade on cortisol and GH response to insulin-induced hypoglycemia in man

1 reference

12 December 2020

Effect of meclastine, a selective H1 receptor antagonist, upon ACTH release

1 reference

12 December 2020

Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

A comparison of the neuro-endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers

1 reference

12 December 2020

Acute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteers

1 reference

12 December 2020

Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics

1 reference

12 December 2020

Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects

1 reference

12 December 2020

Adrenergic control of the secretion of anterior pituitary hormones

1 reference

12 December 2020

Increase in urinary cortisol excretion and memory declines: MacArthur studies of successful aging

1 reference

12 December 2020

Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects

1 reference

12 December 2020

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

1 reference

12 December 2020

Cortisol in night-urine: Introduction of a research method in psychoneuroendocrinology

1 reference

12 December 2020

Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia.

1 reference

12 December 2020

Risk factors for neuroleptic-induced movement disorders

1 reference

12 December 2020

Haloperidol and clozapine treatment and their effect on M-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapine

1 reference

12 December 2020

Effects of psychotropic drugs (desimipramine, chlorimipramine, sulpiride and diazepam) on the human HPA axis

1 reference

12 December 2020

[Melatonin and schizophrenia]

1 reference

12 December 2020

Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy men: relationship with body weight regulation

1 reference

12 December 2020

Evidence for two differentially regulated populations of peripheral beta-endorphin-releasing cells in humans.

1 reference

12 December 2020

Endocrine effects of pimozide, a specific dopaminergic blocker

1 reference

12 December 2020

The central adaptation syndrome: psychosocial stress as a trigger for adaptive modifications of brain structure and brain function

1 reference

12 December 2020

Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy

1 reference

12 December 2020

Melatonin immunoreactivity in cerebrospinal fluid of schizophrenic patients and healthy controls

1 reference

12 December 2020

The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy

1 reference

12 December 2020

Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia

1 reference

12 December 2020

Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia

1 reference

12 December 2020

Reduced nocturnal melatonin secretion in chronic schizophrenia: relationship to body weight

1 reference

12 December 2020

The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia

1 reference

12 December 2020

Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy premenopausal women: relationship with body weight regulation

1 reference

12 December 2020

Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia

1 reference

12 December 2020

10.1007/S00213-003-1766-6

Identifiers

DOI

1 reference

5 December 2017

1 reference